These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23540297)

  • 1. Enacting multiple methamphetamines: the ontological politics of public discourse and consumer accounts of a drug and its effects.
    Dwyer R; Moore D
    Int J Drug Policy; 2013 May; 24(3):203-11. PubMed ID: 23540297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
    Härtel-Petri R; Rodler R; Schmeisser U; Steinmann J; Wolfersdorf M
    Psychiatr Prax; 2005 Jan; 32(1):13-7. PubMed ID: 15633070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counterpublic health and the design of drug services for methamphetamine consumers in Melbourne.
    Duff C; Moore D
    Health (London); 2015 Jan; 19(1):51-66. PubMed ID: 24948593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.
    Degenhardt L; Roxburgh A; McKetin R
    Med J Aust; 2007 Apr; 186(7):342-5. PubMed ID: 17407429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychophysiological aspects of amphetamine-methamphetamine abuse.
    Murray JB
    J Psychol; 1998 Mar; 132(2):227-37. PubMed ID: 9529666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meth/amphetamine use and associated HIV: Implications for global policy and public health.
    Degenhardt L; Mathers B; Guarinieri M; Panda S; Phillips B; Strathdee SA; Tyndall M; Wiessing L; Wodak A; Howard J;
    Int J Drug Policy; 2010 Sep; 21(5):347-58. PubMed ID: 20117923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
    Pennay AE; Lee NK
    Drug Alcohol Rev; 2009 Nov; 28(6):636-40. PubMed ID: 19930017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis.
    Ujike H; Sato M
    Ann N Y Acad Sci; 2004 Oct; 1025():279-87. PubMed ID: 15542728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.
    Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M
    Int J Drug Policy; 2016 Dec; 38():16-20. PubMed ID: 27842249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal crush.
    Huff C
    Hosp Health Netw; 2006 Oct; 80(10):59-60, 62, 64. PubMed ID: 17089639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysing pseudoephedrine/methamphetamine policy options in Australia using multi-criteria decision modelling.
    Manning M; Wong GT; Ransley J; Smith C
    Int J Drug Policy; 2016 Jun; 32():85-92. PubMed ID: 27179610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health outcomes associated with methamphetamine use among young people: a systematic review.
    Marshall BD; Werb D
    Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystalline methamphetamine use and methamphetamine-related harms in Australia.
    Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD
    Drug Alcohol Rev; 2017 Mar; 36(2):160-170. PubMed ID: 27286742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine psychosis: insights from the past.
    McKetin R
    Addiction; 2018 Aug; 113(8):1522-1527. PubMed ID: 29516555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The place and time of drugs.
    Duff C
    Int J Drug Policy; 2014 May; 25(3):633-9. PubMed ID: 24412676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.